Sung-han Lin1, Chih-Chien Tsai1, Yi-Chun Chen2,3, and Jiun-Jie Wang1
1Department of Medical Imaging and Radiological Sciences, Chang-Gung University, TaoYuan, Taiwan, 2Department of Neurology, Chang Gung Memorial Hospital Linkou Medical Center, TaoYuan, Taiwan, 3College of Medicine, Chang Gung University, TaoYuan, Taiwan
Synopsis
Improvement of diagnosis in patients with Mild
Cognitive Impairment (MCI) would help in the early diagnosis of Alzheimer's
Disease (AD), since MCI was known as the transition state from normal aging to
AD. We developed a novel feature extraction algorithm, which was based on the disease
clinical-pathological understanding and combined with the spatial information
between disease affected pattern and its surrounding regions. This novel feature
set demonstrated improved diagnostic performance, compared to the conventional
feature set, especially for the MCI patients. In addition, the identified disease
affected pattern corresponded with the postmortem pathology of amyloid deposition in AD patients.
INTRODUCTION
Mild Cognitive Impairment (MCI) was
known as the transition state from normal aging to AD 1. Improvement of diagnosis in MCI patients would help in the
early diagnosis of AD. In previous machine-based diagnosis studies, the features
either focused on the hippocampus and its surrounding areas 2, 3.
However, AD/MCI caused neurodegeneration is subtle in multiple brain regions
spontaneously 4.
In the current study, we developed a
feature extraction algorithm based on a clinical-pathological understanding of
the disease and combined with the spatial information between disease affected pattern
and its surrounding regions. Applied with the diffusion tensor imaging derived
indices, the selected features would sensitively reveal subtle changes in the
brain and benefit for disease diagnosis as early as possible.METHODS
In total, 499 subjects with AD (34
men and 58 women; mean age: 71.2 ± 12.9 years), MCI (67 men and 80 women; mean
age: 69.2 ± 7.7 years), and healthy controls (HC, 113 men and 147 women; mean
age: 61.3 ± 8.0 years) were recruited respectively (IRB: 201601386B0).
All subjects were randomly divided into the training and testing datasets with an
80:20 ratio, respectively.
Images were acquired using a 3T MR scanner (MAGNETOM
Trio a TIM system, Siemens, Erlangen, Germany) with T1-MPRAGE images (TR / TE =
2000 / 2.63 ms, 160 axial slices of voxel size = 1 × 1 × 1 mm3, inversion time
= 900 ms, flip angle = 9º) and Diffusion-weighted images (DWI) were acquired
(TR/TE = 7324 / 83 ms, 64 axial slices of voxel size = 2 × 2 × 2 mm3, b-value
= 1000 s/mm2 with the 64 non-collinear diffusion-weighted gradient directions).
The primary
and secondary feature sets were extracted from four diffusion tensor image (DTI)
derived images (Mean Diffusivity, Fractional Anisotropy, Axial Diffusivity, and
Radial Diffusivity) reconstructed from DWI. The primary feature set was extracted
from the 10th, 50th, and 90th percentiles of 116 parcellated brain
regions, and 1392 features were extracted (Figure 1A). The parcellation of the
whole brain image would be achieved by overlaid the DTI derived indices, the
parenchyma mask, and individualized Automated Anatomical Labeling (AAL)
template, which was applied with the inversed transformation matrix from the
individual’s non-diffusion weighted image (B0) to the standard
space. The disease affected pattern was identified from the primary feature set
with a statistical approach selection procedure, including the group difference
selection (ANOVA) and the Correlation-Occurrence Selection (COS). In addition,
the one-ROI-one-feature strategy was applied to the selected
primary feature set.
The secondary features were designed
to reflect slopes on the edge of affected regions. Specifically, features were
achieved by calculating the quotient between the difference value and the
corresponding distance between each selected primary feature and its
surrounding areas (Figure 1B). Only slopes involved in the disease affected pattern
were selected. An additional neighborhood selection was applied to the calculated
distance matrix. The group difference filter and COS were applied to the
secondary feature sets to reduce the feature dimension.
The support vector machine (Matlab
R2018a, The MathWorks, Natick, MA) was applied to the classification task. The
diagnostic performance was evaluated by accuracy for each group in the testing
dataset.RESULTS
The
selected secondary features showed significant improvement in classification
accuracy in testing group, when compared to the features from the disease
affected pattern (HC/MCI/AD =81.16±2.96 / 76.72±1.64 / 88.90±1.14% and 72.09±1.69
/ 65.29±2.95 / 83.32±1.40% in the secondary and primary feature set,
respectively). 108/1392 primary features (MD/FA/AD/RD = 29/31/25/23) were
selected as the disease affected pattern and mainly found in basal portions of
the bilateral frontal, temporal, and occipital lobe (Figure 2). On the other
hand, 900 secondary features were derived from the disease affected pattern,
and 102 features (MD/FA/AD/RD = 21/37/31/13) were selected (Figure 3).DISCUSSION
The
current study demonstrated improved diagnostic performance in the disease
affected pattern derived feature set, especially for HC and patients with MCI patients
(approximately 10%, 11% and 6% of testing accuracy in HC, MCI, and AD,
respectively). The disease affected pattern from the primary feature set corresponded
with the postmortem pathology of amyloid deposition, such as the isocortex and
the basal portions of the frontal, temporal and occipital lobe in patients with
AD at the early stages 5. On the other hand, over
88% of selected the primary feature were extreme values since this disease
would cause subtle changes in multiple brain regions is known as one of the
signatures of MCI/AD 5. Most selected secondary
features were links between different extreme values (such as 10th
and 90th percentiles) and might effectively benefit to
classification by enhancing the difference between classes.CONCLUSION
In the current study, we proposed a
novel algorithm to extract image features based on the disease affected
patterns. This newly developed feature set demonstrated the improvement of diagnostic
performance, compared to the primary feature set. The identified pattern from
the primary feature set could reflect the disease-affected pattern and be
similar to the histology evidence. Additionally, visualized network from
selected secondary features further acknowledged the disease affection pattern
in the clinical understanding.Acknowledgements
No acknowledgement found.References
-
Sabbagh
MN, Lue LF, Fayard D, Shi J. Increasing Precision of Clinical Diagnosis of
Alzheimer's Disease Using a Combined Algorithm Incorporating Clinical and Novel
Biomarker Data. Neurol Ther. 2017;6(Suppl 1):83-95.
- Feng F, Wang P, Zhao K, Zhou B, Yao H,
Meng Q, et al. Radiomic Features of Hippocampal Subregions in Alzheimer's
Disease and Amnestic Mild Cognitive Impairment. Front Aging Neurosci.
2018;10:290.
- Zhao K, Ding Y, Han Y, Fan Y,
Alexander-Bloch AF, Han T, et al. Independent and reproducible hippocampal
radiomic biomarkers for multisite Alzheimer’s disease: diagnosis, longitudinal
progress and biological basis. Science Bulletin. 2020;65(13):1103-13.
- Oxtoby NP, Alexander DC, consortium
ftE. Imaging plus X: multimodal models of neurodegenerative disease. Current
Opinion in Neurology. 2017;30(4):371-9.
- Braak H, Braak E. Neuropathological
stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239-59.